LYN-1604 hydrochloride is a potent UNC-51-like kinase 1 (ULK1) activator (EC50=18.94 nM) for the research of triple negative breast cancer (TNBC).
体外研究
LYN-1604 is a potential ULK1 agonist (enzymatic activity=195.7% at 100 nM and IC50=1.66 μM against MDA-MB-231 cells) .
LYN-1604 binds to wild-type ULK1 with a binding affinity in the nanomole range (KD=291.4 nM) .
LYN-1604 (0.5, 1.0 and 2.0 μM) induces cell death via the ULK complex in MDA-MB-231 cells.
LYN-1604 (0.5-2 μM, 24 hours) induces remarkable up-regulation of Beclin-1 and degradation of p62, as well as transformation of LC3-I to LC3-II in MDA-MB-231 cells.
LYN-1604 induces ATG5-dependent autophagy via the ULK complex.
LYN-1604 can also increase cleavage of caspase3 and induce apoptosis.
Cell Viability Assay
Cell Line:
MDA-MB-231 cells
Concentration:
0.5, 1.0 and 2.0 μM
Incubation Time:
Result:
Induced cell death. Autophagy ratio was increased in a dose-dependent manner.
Western Blot Analysis
Cell Line:
MDA-MB-231 cells
Concentration:
0, 0.5, 1, and 2 μM
Incubation Time:
24 hours
Result:
Induced remarkable up-regulation of Beclin-1 and degradation of p62, as well as transformation of LC3-I to LC3-II.
体内研究
LYN-1604 (low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg; intragastric administration once a day for 14 days) inhibits the growth of xenograft TNBC by targeting ULK1-modulated cell death.
Animal Model:
24 female nude mice (BALB/c, 6-8 weeks, 20-22 g)
Dosage:
Low dose, 25 mg/kg; median dose, 50 mg/kg; high dose, 100 mg/kg
Administration:
Intragastric administration; once a day for 14 days
Result:
Significantly inhibited the growth of xenograft MDA-MB-231 cells. The body weights of mice were stable. By the end of the experiment, the liver and spleen weight indexes of mice were slightly increased in parts of the groups, while the kidney weight index was not affected in all dose groups.
分子式
C33H44Cl3N3O2
分子量
621.08
CAS号
2216753-86-3
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
溶解性数据
In Vitro:
DMSO : 100 mg/mL (161.01 mM; Need ultrasonic)
配制储备液
浓度溶剂体积质量
1 mg
5 mg
10 mg
1 mM
1.6101 mL
8.0505 mL
16.1010 mL
5 mM
0.3220 mL
1.6101 mL
3.2202 mL
10 mM
0.1610 mL
0.8050 mL
1.6101 mL
In Vivo:
请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照 In Vitro 方式配制澄清的储备液,再依次添加助溶剂: